Showing results (2131-2140 of 5,702) with videos related to
Sort By:
Pageof 571
The Oncologist|April 3, 2012
Phase II study of bevacizumab in combination with trastuzumab and capecitabine as first-line treatment for HER-2-positive locally recurrent or metastatic breast cancerMiguel Martín, Anatoly Makhson, Joseph Gligorov, et al.The Oncologist|April 28, 2011
Current status of SRC inhibitors in solid tumor malignanciesLauren N Puls, Matthew Eadens, Wells MessersmithThe Oncologist|November 4, 2010
Safety of bevacizumab in patients with advanced cancer: a meta-analysis of randomized controlled trialsSabine Geiger-Gritsch, Bjoern Stollenwerk, Rebecca Miksad, et al.The Oncologist|October 22, 2011
The role of irreversible HER family inhibition in the treatment of patients with non-small cell lung cancerEunice KwakThe Oncologist|October 25, 2011
Use of tamoxifen before and during pregnancyGeert Braems, Hannelore Denys, Olivier De Wever, et al.The Oncologist|May 16, 2012
High let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic diseaseAnnamaria Ruzzo, Francesco Graziano, Bruno Vincenzi, et al.The Oncologist|July 1, 2008
Safety update on erythropoiesis-stimulating agents: trials within and outside the accepted indicationsPere GascónThe Oncologist|July 1, 2008
Hypoxia and aggressive tumor phenotype: implications for therapy and prognosisPeter VaupelThe Oncologist|July 1, 2008
September 2007 update on EORTC guidelines and anemia management with erythropoiesis-stimulating agentsMatti S Aapro, Hartmut LinkThe Oncologist|April 12, 2014
Caring for one of our ownLidia Schapira, Lawrence S Blaszkowsky, Barbara J Cashavelly, et al.Pageof 571